| Year |
Citation |
Score |
| 2020 |
Henn A, He Y, Darou S, Murray K, Fink A, Cundell T, Yerden R. Aseptic conditions for antibiotic-free cell processing for cellular therapies Cytotherapy. 22. DOI: 10.1016/J.Jcyt.2020.03.296 |
0.363 |
|
| 2019 |
Darou S, Henn A, Alm K, Frank AM, Yerden R. Abstract 2157: Eliminating Edge Effect in 96-Well Plates by Controlling Thermal Conditions during Cell Plating Cancer Research. 79: 2157-2157. DOI: 10.1158/1538-7445.Am2019-2157 |
0.336 |
|
| 2018 |
Henn A, Darou S, Yerden R. Abstract 2438: Reducing plate edge effect by controlling cell handling conditions for in vitro tumor hypoxia assays Cancer Research. 78: 2438-2438. DOI: 10.1158/1538-7445.Am2018-2438 |
0.343 |
|
| 2018 |
Henn AD, Darou S, Yerden R. Scaling of massively parallel patient-specific cell cultures with a transportable conditioned cell culture chamber Biochemical Engineering Journal. 132: 139-144. DOI: 10.1016/J.Bej.2018.01.011 |
0.34 |
|
| 2016 |
Henn AD, Darou S, Yerden R. 714. Use of a Modular Workstation for Reduced Biosafety Risks Also Increased Cellular Yields Molecular Therapy. 24: S281. DOI: 10.1016/S1525-0016(16)33522-5 |
0.359 |
|
| 2015 |
Henn AD, Darou S, Yerden R. 471. Cell Incubation Outside of a Barrier Isolator Using an Improved Conditioned Transport Chamber Expands Scale-Out Capacity for Massively Parallel Patient-Specific Batch Production Molecular Therapy. 23: S187. DOI: 10.1016/S1525-0016(16)34080-1 |
0.326 |
|
| 2012 |
Henn AD, Laski M, Yang H, Welle S, Qiu X, Miao H, Barry CT, Wu H, Zand MS. Functionally Distinct Subpopulations of CpG-Activated Memory B Cells. Scientific Reports. 2: 345. PMID 22468229 DOI: 10.1038/Srep00345 |
0.414 |
|
| 2009 |
Henn AD, Rebhahn J, Brown MA, Murphy AJ, Coca MN, Hyrien O, Pellegrin T, Mosmann T, Zand MS. Modulation of single-cell IgG secretion frequency and rates in human memory B cells by CpG DNA, CD40L, IL-21, and cell division. Journal of Immunology (Baltimore, Md. : 1950). 183: 3177-87. PMID 19675172 DOI: 10.4049/Jimmunol.0804233 |
0.424 |
|
| 2006 |
Evans EE, Henn AD, Jonason A, Paris MJ, Schiffhauer LM, Borrello MA, Smith ES, Sahasrabudhe DM, Zauderer M. C35 (C17orf37) is a novel tumor biomarker abundantly expressed in breast cancer. Molecular Cancer Therapeutics. 5: 2919-30. PMID 17121940 DOI: 10.1158/1535-7163.Mct-06-0389 |
0.311 |
|
| 2005 |
Rossi RM, Henn AD, Conkling R, Guzman ML, Bushnell T, Harvey J, Fisher RI, Jordan CT. The PKCβ Selective Inhibitor, Enzastaurin (LY317615), Inhibits Growth of Human Lymphoma Cells. Blood. 106: 1483-1483. DOI: 10.1182/Blood.V106.11.1483.1483 |
0.414 |
|
| 2001 |
Henn AD, Berleth ES, Mihich E, Ehrke MJ. Changes in cytosolic and membrane TNF inhibitory protein-B1 (TIP-B1) levels associated with protection from TNF-induced cytotoxicity. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 15: 1315-7. PMID 11344125 DOI: 10.1096/Fj.00-0543Fje |
0.614 |
|
| 2001 |
Mihich E, Berleth E, Henn A, Ehrke M. Modulation of tumor necrosis factor (TNFα) in cancer therapeutics European Journal of Cancer. 37: S148. DOI: 10.1016/S0959-8049(01)81037-6 |
0.527 |
|
| 2000 |
Berleth ES, Henn AD, Gurtoo HL, Wollman R, Alderfer JL, Mihich E, Ehrke MJ. A novel tumor necrosis factor-alpha inhibitory protein, TIP-B1. International Journal of Immunopharmacology. 22: 1137-42. PMID 11137621 DOI: 10.1016/S0192-0561(00)00071-0 |
0.63 |
|
| 1999 |
Berleth ES, Nadadur S, Henn AD, Eppolito C, Shiojiri S, Gurtoo HL, Ehrke MJ, Mihich E. Identification, characterization, and cloning of TIP-B1, a novel protein inhibitor of tumor necrosis factor-induced lysis. Cancer Research. 59: 5497-506. PMID 10554026 |
0.649 |
|
| Show low-probability matches. |